Th17 and CD24(hi)CD27(+) regulatory B lymphocytes are biomarkers of response to biologics in rheumatoid arthritis
OPEN Arthritis research & therapy | 12 Feb 2017
S Salomon, C Guignant, P Morel, G Flahaut, C Brault, C Gourguechon, P Fardellone, JP Marolleau, B Gubler and V Goëb
The aim was to describe the regulatory B and T cells (Breg and Treg) and T helper 17 (Th17) lymphocytes before and under treatment with biologic drugs, and to assess their potential predictive value as biomarkers of response in rheumatoid arthritis (RA).
* Data courtesy of Altmetric.com